Proton Beam Therapy for Breast Cancer Recurrence
Partial Breast Re-irradiation for Breast Cancer
Recruiting
N/A
Interventional Study
Breast Cancers
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Female
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 20 (estimated)
- Sponsor
- University Hospital Heidelberg · Other
Who this trial is looking for
This trial is looking for women with a recent recurrence of breast cancer who have had previous radiation treatment. Participants will receive proton beam therapy to the breast over several sessions to see how it affects skin reactions.
Are You a Good Fit for This Trial?
You may be able to join if
- I have been diagnosed with recurrent invasive breast cancer or DCIS.
- I have had breast-conserving surgery recently.
- My tumor is less than 3 cm.
- I have no cancer spread to my lymph nodes.
- My surgical margins are clear of cancer.
- It has been at least 12 months since my last radiation treatment.
- I can understand the trial and its consequences.
- I am at least 18 years old.
You may not be able to join if
- I have distant metastases.
- I am currently receiving chemotherapy.
- I have not recovered from the side effects of previous treatments.
- I was diagnosed with cancer within the last 5 years that needs immediate treatment.
- I am pregnant or breastfeeding.
- I am participating in another competing clinical study.
- I have a history of active connective tissue disorder.
- I have medical implants not eligible for the treatment.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
Breast cancer is the most common malignancy in women. Breast-conserving surgery (BCS) with adjuvant whole-breast irradiation (WBI) is currently the standard of care in the oncological treatment of primary breast cancer and offers an equivalent alternative to mastectomy. The primary aim of adjuvant radiotherapy (RT) is to improve local control and thus improve overall survival and breast cancer-spe…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* histologically confirmed recurrent (or new primary) ipsilateral invasive breast cancer or DCIS after prior RT of the ipsilateral breast
* indication for re-irradiation after repeat breast conserving surgery (e.g. lumpectomy, wide excision, …)
* tumor size \< 3 cm
* clinically …
Contacts